T cell repertoire expression in murine recipients of bone marrow transplant after LF 08-0299 (Tresperimus) administration

Transplant Immunology

Volumn 6, Issue 4, 1998, Pages 217-224

  Annat, Jocelyne ^a   Dutartre, Patrick ^a  

^a Laboratoires Fournier SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LF 08 0299; T LYMPHOCYTE RECEPTOR; TRESPERIMUS; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; GRAFT VERSUS HOST REACTION; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; THYMUS;

EID: 0032418607     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(98)80011-7     Document Type: Article

References (34)

1. Ferrara JLM, Deeg HJ. Graft-versus-host disease. N Engl J Med. 324:1991;667-674.
2. Vogelsang GB, Hess AD. Graft-versus-host disease: new directions for a persistent problem. Blood. 84:1994;2061-2067.
3. Ferrara JLM. Cellular and molecular mechanisms of graft-versus-host disease. Transfus Sci. 3:1994;197-206.
4. Korngold R. Biology of graft-vs.-host disease. Am J Pediatr Hematol Oncol. 15:1993;18-27.
5. Hayes JM. The immunobiology and clinical use of current immunosuppressive therapy for renal transplantation. J Urology. 149:1993;437-448.
6. Storb R, Anasetti C, Appelbaum FR, et al. Immunosuppressive agents for prevention of graft-versus-host disease. Bone Marrow Transplant. 15:1995;S98-S103.
7. Tutschka PJ, Beschorner WE, Hess AD, et al. Cyclosporin-A to prevent graft-versus-host disease: a pilot study in 22 patients receiving allogeneic marrow transplants. Blood. 61:1983;318-325.
8. Glazier A, Tutschka PJ, Farmer ER, Santos GV. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med. 158:1983;1-8.
9. Jenkins MK, Schwartz RH, Pardoll DM. Effects of cyclosporine A on T cell development and clonal deletion. Science. 241:1988;1655-1658.
10. Desbarats J, Lapp WS. Thymic selection and thymic major histocompatibility compatibility complex class II expression are abnormal in mice undergoing graft-versus-host reactions. J Exp Med. 178:1993;805-814.
11. Fukushi N, Arase H, Wand B, et al. Thymus: a direct target tissue in graft-versus-host reaction after allogeneic bone marrow transplantation that results in abrogation of induction of self-tolerance. Proc Natl Acad Sci USA. 87:1990;6301-6305.
12. Dietrich PY, Caignard A, Lim A, et al. In vivo T-cell clonal amplification at time of acute graft-versus-host disease. Blood. 84:1994;2815-2820.
13. Liu X, Chesnokova V, Forman SJ, Diamond DJ. Molecular analysis of T-cell receptor repertoire in bone marrow transplant recipients: evidence for oligoclonal T-cell expansion in graft-versus-host disease lesions. Blood. 87:1996;3032-3044.
14. Dutartre P, Annat J, Derrepas P. LF 08-0299 induces tolerance after short-term treatment in a fully major histocompatibility mismatched rat cardiac allograft model. Transplant Proc. 27:1995;440-442.
15. Andoins C, De Fornel D, Annat J, Dutartre P. Tolerance in a rat cardiac allograft model after short-term treatment with LF 08-0299. Absence of clonal deletion and evidence of CD4+ suppressor cells. Transplantation. 62:1996;1543-1549.
16. Annat J, Churaqui E, Dutartre P, Bruley-Rosset M. Prevention of lethal graft-versus-host disease following allogeneic bone marrow transplantation in mice by short course administration of LF 08-0299. Transplantation. 62:1996;721-729.
17. Frankel WN, Rudy C, Coffin JM, Huber BT. Linkage of Mls genes to endogenous mammary tumour viruses of inbred mice. Nature. 349:1991;526-528.
18. Abe R, Foo-Phillips M, Hodes RJ. Genetic analysis of the Mls system: formal Mls typing of the commonly used inbred strains. Immunogenetics. 33:1991;62-73.
19. Abe R, Kanagawa O, Sheard MA, Malissen B, Foo-Phillips M. Characterization of a new minor lymphocyte stimulatory system. I. Cluster of self antigens recognized by I-E-reactive Vßs, Vß5, Vß11 and Vß12 T cell receptors for antigen. J Immunol. 147:1991;739-749.
20. Woodland DL, Happ MP, Gollod KJ, Palmer E. An endogeneous retrovirus mediating deletion of α/β T cells. Nature. 349:1991;529-530.
21. Iseki R, Mukai M, Iwata M. Regulation of T lymphocyte apoptosis. Signals for the antagonism between activation- and glucocorticoid-induced death. J Immunol. 147:1991;4286-4292.
22. Kosugi A, Sharrow SO, Shearer GM. Effect of cyclosporin A on lymphophoiesis. I. Absence of mature T cells in thymus and periphery of bone marrow transplanted mice trated with cyclosporin A. J Immunol. 142:1989;3026-3032.
23. Wang B, Benoist C, Mathis D. The immunosuppressant 1,5-deoxyspergualin reveals commonality between preT and preB cell differentiation. J Exp med. 183:1996;2427-2436.
24. Bryson JS, Jennings CD, Caywood BE, Kaplan AM. Induction of a syngeneic graft-versus-host disease-like syndrome in DBA/2 mice. Transplantation. 48:1989;1042-1047.
25. Beschorner WE, Ren H, Phillips J, Pulido HB, Hruban RH, Hess AD. Prevention of syngeneic graft-versus-host disease by recovery of thymic microenvironment after cyclosporine. Transplantation. 52:1991;668-674.
26. Bucy RP, Xu XY, Li J, Huang GQ. Cyclosporin A-induced autoimmune disease in mice. J Immunol. 151:1993;1039-1050.
27. Fischer AC, Ruvolo PP, Burt R, et al. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. J Immunol. 154:1995;3713-3725.
28. Hirano M, Arase H, Arase-Fukushi N, et al. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets. Cell Immunol. 151:1993;118-132.
29. Hollander GA, Widmer B, Burakoff SJ. Loss of normal thymic repertoire selection and persistence of autoreactive T cells in graft vs host disease. J Immunol. 152:1994;1609-1617.
30. Parkman R. Clonal analysis of murine graft-vs-host disease: I. phenotypic and functional analysis of T lymphocytes clones. J Immunol. 136:1986;3543-3548.
31. Howell CD, Li J, Roper E, Kotzin BL. Biased liver T cell receptor Vß repertoire in a murine graft-versus-host disease model. J Immunol. 155:1995;2350-2358.
32. Jones MS, Riley R, Hamilton BL, et al. Endogeneous superantigens in allogeneic bone marrow transplant recipients rapidly and selectively expand donor T cells which can produce INFγ Bone Marrow Transplant. 14:1994;725-735.
33. Miconnet I, de La Selle V, Bruley-Rosset M. Relative importance of CD4+ and CD8+ T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation. Bone Marrow Transplant. 21:1998;583-590.
34. Blazar BR, Taylor PA, Snover DC, Sehgal SN, Vallera DA. Murine recipients of fully mismatched donor marrow are protected from lethal graft-versus-host disease by in vivo administration of rapamycin but develop an autoimmune-like syndrome. J Immunol. 151:1993;5726-5741.